This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Pfizer Inc.

Drug Names(s): Alprazolam

Description: Xanax (alprazolam) is a short-acting drug benzodiazepine used to treat anxiety disorders and as an adjunctive treatment for depression. Xanax binds to the GABA-A subtype of the GABA receptor, increasing inhibitory effects of GABA within the central nervous system. The binding site for benzodiazepines is distinct from the binding site for barbiturates and GABA on the GABA receptor.

Deal Structure: XANAX XR tablets are the extended-release formulations of Xanax.

All historical revenue for Xanax & Xanax XR is recorded under Xanax XR.

Xanax News

Pink Sheet Xanax XR approved

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug